Form D · Biotechnology
Biophysical Therapeutics, Inc.
Wilmington, DE · CIK 0001980213
Offering snapshot reported Aug 21, 2023 · SEC filing
- Reported sold
- $35K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Aug 21, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 21, 2023 | Initial | $35,000 | No comparison | 1 | SEC filing |
| Jun 7, 2023 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-490239
Simple Agreement for Future Equity (SAFE)
Source: Form D, filed Aug 21, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Forrest David Michael | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Csc, 251 Little Falls Dr
Wilmington, DE, 19808
Wilmington, DE, 19808